240 related articles for article (PubMed ID: 32711725)
1. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.
Bancos I; Taylor AE; Chortis V; Sitch AJ; Jenkinson C; Davidge-Pitts CJ; Lang K; Tsagarakis S; Macech M; Riester A; Deutschbein T; Pupovac ID; Kienitz T; Prete A; Papathomas TG; Gilligan LC; Bancos C; Reimondo G; Haissaguerre M; Marina L; Grytaas MA; Sajwani A; Langton K; Ivison HE; Shackleton CHL; Erickson D; Asia M; Palimeri S; Kondracka A; Spyroglou A; Ronchi CL; Simunov B; Delivanis DA; Sutcliffe RP; Tsirou I; Bednarczuk T; Reincke M; Burger-Stritt S; Feelders RA; Canu L; Haak HR; Eisenhofer G; Dennedy MC; Ueland GA; Ivovic M; Tabarin A; Terzolo M; Quinkler M; Kastelan D; Fassnacht M; Beuschlein F; Ambroziak U; Vassiliadi DA; O'Reilly MW; Young WF; Biehl M; Deeks JJ; Arlt W;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):773-781. PubMed ID: 32711725
[TBL] [Abstract][Full Text] [Related]
2. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W
J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449
[TBL] [Abstract][Full Text] [Related]
3. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
Sane T; Schalin-Jäntti C; Raade M
J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
[TBL] [Abstract][Full Text] [Related]
4. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
Halefoglu AM; Bas N; Yasar A; Basak M
Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study.
Ebbehoj A; Li D; Kaur RJ; Zhang C; Singh S; Li T; Atkinson E; Achenbach S; Khosla S; Arlt W; Young WF; Rocca WA; Bancos I
Lancet Diabetes Endocrinol; 2020 Nov; 8(11):894-902. PubMed ID: 33065059
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling.
Bancos I; Arlt W
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):200-207. PubMed ID: 28234802
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study.
Prete A; Subramanian A; Bancos I; Chortis V; Tsagarakis S; Lang K; Macech M; Delivanis DA; Pupovac ID; Reimondo G; Marina LV; Deutschbein T; Balomenaki M; O'Reilly MW; Gilligan LC; Jenkinson C; Bednarczuk T; Zhang CD; Dusek T; Diamantopoulos A; Asia M; Kondracka A; Li D; Masjkur JR; Quinkler M; Ueland GÅ; Dennedy MC; Beuschlein F; Tabarin A; Fassnacht M; Ivović M; Terzolo M; Kastelan D; Young WF; Manolopoulos KN; Ambroziak U; Vassiliadi DA; Taylor AE; Sitch AJ; Nirantharakumar K; Arlt W; ;
Ann Intern Med; 2022 Mar; 175(3):325-334. PubMed ID: 34978855
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
[TBL] [Abstract][Full Text] [Related]
10. Incidental Adrenal Nodules in Patients Without Known Malignancy: Prevalence of Malignancy and Utility of Washout CT for Characterization-A Multiinstitutional Study.
Corwin MT; Badawy M; Caoili EM; Carney BW; Colak C; Elsayes KM; Gerson R; Klimkowski SP; McPhedran R; Pandya A; Pouw ME; Schieda N; Song JH; Remer EM
AJR Am J Roentgenol; 2022 Nov; 219(5):804-812. PubMed ID: 35731098
[No Abstract] [Full Text] [Related]
11. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations.
Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H
AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489
[TBL] [Abstract][Full Text] [Related]
12. Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.
Buitenwerf E; Korteweg T; Visser A; Haag CMSC; Feelders RA; Timmers HJLM; Canu L; Haak HR; Bisschop PHLT; Eekhoff EMW; Corssmit EPM; Krak NC; Rasenberg E; van den Bergh J; Stoker J; Greuter MJW; Dullaart RPF; Links TP; Kerstens MN
Eur J Endocrinol; 2018 May; 178(5):431-437. PubMed ID: 29467230
[TBL] [Abstract][Full Text] [Related]
13. Not all adrenal incidentalomas require biochemical testing to exclude pheochromocytoma: Mayo clinic experience and a meta-analysis.
Gruber LM; Strajina V; Bancos I; Murad MH; Dy BM; Young WF; Farley DR; Lyden ML; Thompson GB; McKenzie TJ
Gland Surg; 2020 Apr; 9(2):362-371. PubMed ID: 32420260
[TBL] [Abstract][Full Text] [Related]
14. Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
Patel D; Thompson MD; Manna SK; Krausz KW; Zhang L; Nilubol N; Gonzalez FJ; Kebebew E
Clin Cancer Res; 2017 Sep; 23(17):5302-5310. PubMed ID: 28450405
[No Abstract] [Full Text] [Related]
15. Adrenocortical tumours: high CT attenuation value correlates with eosinophilia but does not discriminate lipid-poor adenomas from malignancy.
Pennanen M; Raade M; Louhimo J; Sane T; Heiskanen I; Arola J; Haglund C
J Clin Pathol; 2013 Dec; 66(12):1076-80. PubMed ID: 23908452
[TBL] [Abstract][Full Text] [Related]
16. Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
Tessonnier L; Sebag F; Palazzo FF; Colavolpe C; De Micco C; Mancini J; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2018-25. PubMed ID: 18566816
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of ct in examination of patients with adrenal cancer].
Rusakov VF; Shcherbakov IE; Chinchuk IK; Savelyeva TV; Rebrova DV; Loginova OI; Pridvizhkina TS; Chernikov RA; Krasnov LM; Fedotov JN; Fedorov EA; Sablin IV; Sleptsov IV; Shihmagomedov SS; Zgoda EA
Probl Endokrinol (Mosk); 2022 Apr; 68(4):13-29. PubMed ID: 36104962
[TBL] [Abstract][Full Text] [Related]
18. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
[TBL] [Abstract][Full Text] [Related]
19. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854
[TBL] [Abstract][Full Text] [Related]
20. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
